Sobetirome – 5 mg

Brand:
Cayman
CAS:
211110-63-3
Storage:
-20
UN-No:
Non-Hazardous - /

Sobetirome is an agonist of thyroid hormone receptor β (TRβ; EC50 = 7 nM in a reporter assay).{52772} It selectively binds to TRβ over TRα with Kd values of 0.1 and 1.8 nM, respectively. Sobetirome (97 nmol/kg, i.p.) increases hepatic levels of the HDL receptor SR-B1 and serum levels of C4, a marker of increased bile acid synthesis, in mice fed normal chow or high-cholesterol diets.{52773} It reduces serum cholesterol and triglyceride levels in these same models. Sobetirome (154 nmol/kg, i.p.) also decreases plasma cholesterol levels, without increasing heart rate, in a mouse model of hypothyroidism induced by an iodine-deficient diet containing the thyroid hormone biosynthesis inhibitor 5-propyl-2-thio-uracil.{52774}  

 

Available on backorder

SKU: 30814 - 5 mg Category:

Description

A TRβ agonist (EC50 = 7 nM in a reporter assay); selectively binds to TRβ over TRα (Kds = 0.1 and 1.8 nM, respectively); increases hepatic SR-B1 levels and serum C4 levels in mice fed normal chow or high-cholesterol diets at 97 nmol/kg; reduces serum cholesterol and triglyceride levels in these same models; decreases plasma cholesterol levels in a mouse model of hypothyroidism induced by an iodine-deficient diet containing 5-propyl-2-thio-uracil at 154 nmol/kg


Formal name: 2-[4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-acetic acid

Synonyms:  GC-1|QRX 431

Molecular weight: 328.4

CAS: 211110-63-3

Purity: ≥98%

Formulation: A solid